VGHCX
Vanguard Health Care Fund Investor Shares
1W: -2.6%
1M: -5.6%
3M: -2.5%
YTD: -0.6%
1Y: +7.0%
3Y: +19.7%
5Y: +19.8%
$203.46
-0.50 (-0.25%)
Weekly Expected Move ±2.0%
$196
$200
$204
$208
$212
ETF-Level Metrics
AUM$38.9B
Holdings88
Top 10 Wt40.7%
Beta0.54
% Profitable54%
Coverage98%
Portfolio Valuation
P/E14.2
P/B2.5
P/S2.1
EV/EBITDA14.2
P/FCF17.6
PEG0.80
Profitability & Returns
Gross Margin60.6%
Net Margin15.0%
ROE18.2%
ROA10.4%
ROIC18.6%
Div Yield1.23%
Leverage & Liquidity
Debt/Equity0.24
Debt/Assets0.13
Net Debt/EBITDA-0.1x
Interest Cov29.2x
Current Ratio2.11
Quick Ratio1.62
Growth (YoY)
Revenue+23.4%
Net Income+19.1%
EPS+22.7%
FCF+49.1%
EBITDA+28.8%
Rev CAGR 3Y+21.3%
Quality Scores
Piotroski F6.2
Altman Z13.59
IS Quality73.2
IS Overall61.6
IS Value45.6
Median P/E15.3
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 88 | 98.4% | -1.7 |
| Other | 15 | 1.3% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | 0.45% | 3 | Bullish | 2 | 0 | +84.6% |
Showing 50 of 103 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY.SW | 9.08% | $3.3B | 3,582,833 | 38.2 | $851.6B | Healthcare |
| 2 | Merck & Co Inc | 6MK.DE | 5.41% | $2.0B | 18,279,775 | 114.5 | $314.9B | Healthcare |
| 3 | AstraZeneca PLC | ZEG.DE | 5.09% | $2.6B | 9,897,175 | 23.4 | $249.2B | Healthcare |
| 4 | UnitedHealth Group Inc | UNH.DE | 3.92% | $1.4B | 3,895,307 | 23.9 | $295.9B | Healthcare |
| 5 | Johnson & Johnson | JNJ.SW | 3.45% | $1.3B | 5,527,324 | 29.6 | $535.1B | Healthcare |
| 6 | Edwards Lifesciences Corp | EW | 3.21% | $1.2B | 14,158,652 | 48.9 | $49.0B | Healthcare |
| 7 | GSK PLC | GLAXF | 3.13% | $1.6B | 44,002,585 | 14.8 | $91.2B | Healthcare |
| 8 | Intuitive Surgical Inc | 0R29.L | 2.71% | $1.0B | 2,186,666 | 44.3 | $140.2B | Healthcare |
| 9 | Boston Scientific Corp | BSX.F | 2.36% | $868.2M | 15,070,438 | 17.2 | $55.9B | Healthcare |
| 10 | Danaher Corp | DAP.DE | 2.35% | $865.5M | 4,836,473 | 37.9 | $134.5B | Healthcare |
| 11 | CVS Health Corp | CVS.DE | 2.20% | $812.6M | 9,756,578 | 22.6 | $98.2B | Healthcare |
| 12 | Argenx SE | ARGNF | 2.20% | $953.7M | 1,036,146 | 33.3 | $58.2B | Healthcare |
| 13 | Abbott Laboratories | ABT.SW | 2.18% | $802.8M | 8,842,005 | 31.4 | $125.5B | Healthcare |
| 14 | Vertex Pharmaceuticals Inc | VX1.DE | 2.09% | $770.1M | 1,801,919 | 29.1 | $113.3B | Healthcare |
| 15 | Cencora Inc | ABC | 2.08% | $765.2M | 2,484,451 | 13.3 | $36.1B | Healthcare |
| 16 | Elevance Health Inc | ANTM | 1.90% | $699.5M | 1,858,361 | 2.1 | $114.6B | Healthcare |
| 17 | Regeneron Pharmaceuticals Inc | 0R2M.L | 1.79% | $658.9M | 931,886 | 17.6 | $79.6B | Healthcare |
| 18 | UCB SA | UCB.BR | 1.74% | $752.7M | 2,355,442 | 17.7 | $38.9B | Healthcare |
| 19 | Novartis AG | NOVN.SW | 1.62% | $764.8M | 4,043,167 | 21.3 | $221.1B | Healthcare |
| 20 | HCA Healthcare Inc | 0J1R.L | 1.42% | $522.8M | 1,203,410 | 14.2 | $96.2B | Healthcare |
| 21 | Alnylam Pharmaceuticals Inc | 0HD2.L | 1.40% | $517.1M | 1,670,679 | 36.0 | $29.7B | Healthcare |
| 22 | AbbVie Inc | 4AB.DE | 1.35% | $497.9M | 2,356,112 | 74.0 | $408.1B | Healthcare |
| 23 | Biogen Inc | BIIB.SW | 1.30% | $478.1M | 2,526,097 | 30.0 | $20.8B | Healthcare |
| 24 | United Therapeutics Corp | UTHR | 1.28% | $470.2M | 822,896 | 17.9 | $23.0B | Healthcare |
| 25 | Galderma Group AG | GALD.SW | 1.27% | $598.4M | 2,228,631 | 47.4 | $37.4B | Healthcare |
| 26 | Chugai Pharmaceutical Co Ltd | 4519.T | 1.25% | $2.9M | 8,606,142 | 21.1 | $9.9T | Healthcare |
| 27 | Roche Holding AG | ROP.SW | 1.24% | $585.4M | 1,122,465 | 22.5 | $275.2B | Healthcare |
| 28 | Otsuka Holdings Co Ltd | OTSKF | 1.23% | $2.9M | 6,207,200 | 14.7 | $38.4B | Healthcare |
| 29 | Cardinal Health Inc | 0HTG.L | 1.21% | $447.0M | 2,317,298 | 31.4 | $53.8B | Healthcare |
| 30 | Agilent Technologies Inc | 0HAV.L | 1.20% | $441.9M | 3,824,222 | 33.0 | $53.3B | Healthcare |
| 31 | Shionogi & Co Ltd | 4507.T | 1.12% | $2.6M | 20,439,649 | 9.0 | $2.4T | Healthcare |
| 32 | Dexcom Inc | DXCM | 1.03% | $379.0M | 6,365,180 | 33.0 | $32.2B | Healthcare |
| 33 | Daiichi Sankyo Co Ltd | 4568.T | 1.00% | $2.4M | 22,675,166 | 20.5 | $4.9T | Healthcare |
| 34 | Thermo Fisher Scientific Inc | TN8.DE | 0.97% | $357.2M | 745,695 | 35.2 | $214.6B | Healthcare |
| 35 | Genmab A/S | GNMSF | 0.97% | $56.0M | 1,345,944 | 26.5 | $21.8B | Healthcare |
| 36 | Medtronic PLC | 2M6.DE | 0.93% | $342.4M | 4,228,128 | 21.1 | $98.6B | Healthcare |
| 37 | Stryker Corp | 0R2S.L | 0.83% | $305.8M | 970,510 | 28.3 | $103.0B | Healthcare |
| 38 | Ionis Pharmaceuticals Inc | 0JDI.L | 0.77% | $284.3M | 3,803,181 | -12.6 | $7.1B | Healthcare |
| 39 | REVOLUTION Medicines Inc | RVMD | 0.72% | $265.0M | 1,838,404 | -23.3 | $43.9B | Healthcare |
| 40 | Ascendis Pharma A/S | ASND | 0.65% | $240.8M | 1,049,942 | 16.7 | $14.2B | Healthcare |
| 41 | STERIS PLC | STE | 0.64% | $237.0M | 1,092,821 | 25.4 | $20.3B | Healthcare |
| 42 | Incyte Corp | 0J9P.L | 0.61% | $225.4M | 2,365,620 | 14.2 | $22.8B | Healthcare |
| 43 | QIAGEN NV | QIA.DE | 0.61% | $225.3M | 6,514,443 | 22.9 | $8.3B | Healthcare |
| 44 | Cytokinetics Inc | CYTK | 0.60% | $222.8M | 3,482,614 | -9.1 | $8.2B | Healthcare |
| 45 | Bristol-Myers Squibb Co | BMY.SW | 0.60% | $221.9M | 3,661,639 | 13.5 | $87.7B | Healthcare |
| 46 | Eisai Co Ltd | ESALF | 0.60% | $1.4M | 7,339,417 | 31.3 | $8.6B | Healthcare |
| 47 | Madrigal Pharmaceuticals Inc | MDGL | 0.57% | $211.6M | 408,918 | -38.7 | $11.5B | Healthcare |
| 48 | ICON PLC | ICLR | 0.49% | $182.0M | 1,538,110 | 37.8 | $12.4B | Healthcare |
| 49 | Novo Nordisk A/S | NOVO-B.CO | 0.48% | $27.6M | 4,131,421 | 9.5 | $1.1T | Healthcare |
| 50 | CG oncology Inc | CGON | 0.47% | $172.8M | 2,589,248 | -25.0 | $5.9B | Healthcare |